Shilpa Pharma delivers world-class CDMO services to Russia, supporting pharmaceutical and biotech companies with high-quality, compliant, and scalable manufacturing solutions from India. As a globally trusted Contract Development and Manufacturing Organization (CDMO), we combine international quality standards, advanced manufacturing technologies, and deep scientific expertise to help Russian companies accelerate product development and commercialization.
With global regulatory approvals including USFDA, EU GMP, PMDA, ANVISA, COFEPRIS, KFDA, and TGA, Shilpa Pharma is recognized for its robust quality systems, strong regulatory compliance, and proven performance in regulated markets. Our state-of-the-art facilities specialize in oncology, high-potency APIs, complex generics, specialty therapeutics, biologics, and end-to-end formulation development, ensuring consistent quality, strict confidentiality, and reliable global supply.
For Russian companies seeking cost-effective manufacturing in India, advanced high-potency handling capabilities, or a long-term CDMO partner for complex and specialty formulations, Shilpa Pharma delivers solutions tailored to Russian market requirements. Our focus on precision, compliance, innovation, and on-time delivery makes us a dependable CDMO partner for Russia’s evolving pharmaceutical and biotech landscape.
Partner with Shilpa Pharma—where global science, regulatory excellence, and world-class manufacturing come together to support Russian pharmaceutical companies with reliable CDMO services from India.



Leading the Way in Pharma Innovation

Established

R&D workforce

Team size

Manufacturing site

Audits

Customers

Projects
Shilpa Pharma is a preferred CDMO partner for pharmaceutical companies worldwide, trusted for precision manufacturing, consistent reliability, and deep technical expertise. With strong capabilities in CDMO services for Russian pharmaceutical companies, we support partners who require global-quality standards and uncompromising regulatory compliance.
Our key strength lies in the ability to manufacture complex, rare, and high-value molecules that only a limited number of manufacturers globally can deliver. From advanced oncology compounds to specialty intermediates, every process is executed under strict international guidelines to ensure exceptional purity, safety, and batch-to-batch consistency.
Pharmaceutical companies in Russia and other regulated markets rely on our transparent operations, robust documentation, and proven on-time delivery performance. When companies seek a CDMO partner that combines scientific excellence with manufacturing reliability, they choose Shilpa Pharma—where quality is not a promise, but a standard.
Shilpa Pharma is a globally trusted partner for CDMO API manufacturing and supply for Russia, delivering high-quality Active Pharmaceutical Ingredients (APIs) that meet stringent international regulatory standards. With decades of expertise in complex chemistry, oncology APIs, HPAPIs, peptides, and rare specialty compounds, we support Russian pharmaceutical and biotech companies with reliable, scalable, and fully compliant API solutions.
Our world-class manufacturing facilities in India operate under rigorous global certifications, including USFDA, EU GMP, PMDA, ANVISA, COFEPRIS, KFDA, and TGA, ensuring every API is manufactured with uncompromising quality, safety, and documentation standards. From early-stage development to commercial-scale production, our teams bring deep scientific expertise, strong process optimization capabilities, and advanced containment technologies.
We specialize in:
With robust infrastructure, automation-driven processes, and strict impurity profiling, Shilpa Pharma ensures consistent quality, high purity, and reliable supply to the Russian market. Our CDMO approach is built on transparency, regulatory excellence, and long-term partnerships—helping Russian companies reduce manufacturing risk, accelerate product timelines, and achieve sustainable commercial success.
Whether you are looking for a dependable API supplier, a development partner, or comprehensive CDMO support, Shilpa Pharma delivers end-to-end API manufacturing solutions from India for Russia, backed by global compliance and scientific excellence.
Get our capability overview via email